Area of research
Oncology · Pediatrics, Perinatology and Child Health
Research interest
Research interests include Medicine, Breast cancer, Quality of life (healthcare), Randomized controlled trial, Physical therapy, and Psychosocial.
Supervised Exercise for Patients With Metastatic Breast Cancer: A Cost-Utility Analysis Alongside the PREFERABLE-EFFECT Randomized Controlled Trial
Impact of exercise on sexual health, body image, and therapy‐related symptoms in women with metastatic breast cancer: The randomized controlled <scp>PREFERABLE</scp>‐<scp>EFFECT</scp> trial
Supervised, structured and individualized exercise in metastatic breast cancer: a randomized controlled trial
Abstract GS02-10: Effects of a structured and individualized exercise program on fatigue and health-related quality of life in patients with metastatic breast cancer: the multinational randomized controlled PREFERABLE-EFFECT study
A Negative Body Image among Adolescent and Young Adult (AYA) Cancer Survivors: Results from the Population-Based SURVAYA Study
Patient-Reported Symptoms of Late Toxicity in Patients With Breast Cancer Treated With Hypofractionated Radiation Therapy and the Association With Quality of Life
(Ex-)breast cancer patients with (pre-existing) symptoms of anxiety and/or depression experience higher barriers to contact health care providers during the COVID-19 pandemic
The impact of the COVID-19 pandemic on perceived access to health care and preferences for health care provision in individuals (being) treated for breast cancer
Impact of the COVID-19 Pandemic on Patient-Reported Outcomes of Breast Cancer Patients and Survivors
Breast Edema Following Breast-Conserving Surgery and Radiotherapy: Patient-Reported Prevalence, Determinants, and Effect on Health-Related Quality of Life
The effect of chemotherapy on subjective cognitive function in younger early-stage breast cancer survivors treated with chemotherapy compared to older patients
The risk of cardiovascular disease following breast cancer by Framingham risk score
Am I My Family's Keeper? Disclosure Dilemmas in Next-Generation Sequencing